George L. Melikian
Infectious Disease
11333 Sepulveda Boulevard
Floor 3
Mission Hills, CA 91345
Floor 3
Mission Hills, CA 91345
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa.
Journal: PloS one
Published: April 15, 2015
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.
Journal: The Journal of antimicrobial chemotherapy
Published: August 13, 2013
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
Journal: Antimicrobial agents and chemotherapy
Published: March 29, 2013
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.
Journal: Antimicrobial agents and chemotherapy
Published: June 06, 2012
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.
Journal: Antimicrobial agents and chemotherapy
Published: February 15, 2012
Aspergillosis in the 'nonimmunocompromised' host.
Journal: Immunological investigations
Published: October 12, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026